CITIGROUP INC - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$1,000
-95.0%
3,478
-95.7%
0.00%
Q1 2016$20,000
+66.7%
81,527
+135.3%
0.00%
Q4 2015$12,000
-52.0%
34,645
+135.5%
0.00%
Q3 2015$25,000
-54.5%
14,713
-41.3%
0.00%
Q2 2015$55,000
+25.0%
25,063
+9.8%
0.00%
Q1 2015$44,000
-56.4%
22,819
-40.3%
0.00%
Q4 2014$101,000
+494.1%
38,213
+564.2%
0.00%
Q3 2014$17,000
+21.4%
5,753
+66.0%
0.00%
Q2 2014$14,000
-84.6%
3,465
-83.4%
0.00%
Q1 2014$91,000
-48.0%
20,927
-37.0%
0.00%
Q4 2013$175,000
+63.6%
33,242
+95.7%
0.00%
Q3 2013$107,000
+463.2%
16,983
+337.3%
0.00%
Q2 2013$19,0003,8840.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders